New Antibody Advances 2021 International Clinical Webinar

The One Lambda LABScreen product portfolio continues to improve advances in HLA antibody detection by our continued research to develop more stable HLA class II antigens, reducing potential denatured reactions in HLA antibody tests due to pan DR activity. Learn how the LABScreen ReFlex platform removes pan-DR reactivity, resolves discordant class II reactivity, and reveals true specificity for HLA class II antigens. Also learn about PreSorb, which removes an autoreactive antibody in serum that recognizes an antigenic determinant for all DR alleles as well as Cw1, Cw12, and Cw15 epitopes.